92 related articles for article (PubMed ID: 26416047)
1. Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associated with susceptibility to breast cancer.
Ullah Shah A; Mahjabeen I; Kayani MA
J BUON; 2015; 20(4):985-93. PubMed ID: 26416047
[TBL] [Abstract][Full Text] [Related]
2. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
3. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
6. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
7. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
9. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
10. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
[TBL] [Abstract][Full Text] [Related]
11. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore.
Ceschi M; Sun CL; Van Den Berg D; Koh WP; Yu MC; Probst-Hensch N
Carcinogenesis; 2005 Aug; 26(8):1457-64. PubMed ID: 15845652
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
[TBL] [Abstract][Full Text] [Related]
13. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
14. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
[TBL] [Abstract][Full Text] [Related]
15. Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.
Soleimani Z; Kheirkhah D; Sharif MR; Sharif A; Karimian M; Aftabi Y
Pathol Oncol Res; 2017 Jul; 23(3):621-631. PubMed ID: 28004353
[TBL] [Abstract][Full Text] [Related]
16. The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Weitzer W; Leithner A; Samonigg H
Breast Cancer Res Treat; 2003 Dec; 82(3):165-8. PubMed ID: 14703063
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.
Justenhoven C; Pierl CB; Haas S; Fischer HP; Hamann U; Baisch C; Harth V; Spickenheuer A; Rabstein S; Vollmert C; Illig T; Pesch B; Brüning T; Dippon J; Ko YD; Brauch H
Int J Cancer; 2009 May; 124(9):2077-81. PubMed ID: 19142864
[TBL] [Abstract][Full Text] [Related]
18. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
[TBL] [Abstract][Full Text] [Related]
19. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
Sabir M; Baig RM; Mahjabeen I; Kayani MA
Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]